CN111943939B - Synthesis method of chromanone compound and agricultural biological activity thereof - Google Patents

Synthesis method of chromanone compound and agricultural biological activity thereof Download PDF

Info

Publication number
CN111943939B
CN111943939B CN202010759339.5A CN202010759339A CN111943939B CN 111943939 B CN111943939 B CN 111943939B CN 202010759339 A CN202010759339 A CN 202010759339A CN 111943939 B CN111943939 B CN 111943939B
Authority
CN
China
Prior art keywords
compound
hydrogen
synthesis method
chromanone
allyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202010759339.5A
Other languages
Chinese (zh)
Other versions
CN111943939A (en
Inventor
王祖利
陈德茂
孙媛媛
韩晴晴
杨洪迪
丁彩真
王艳丽
杨少慧
李娜
宋敬城
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Qingdao Agricultural University
Original Assignee
Qingdao Agricultural University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Qingdao Agricultural University filed Critical Qingdao Agricultural University
Priority to CN202010759339.5A priority Critical patent/CN111943939B/en
Publication of CN111943939A publication Critical patent/CN111943939A/en
Application granted granted Critical
Publication of CN111943939B publication Critical patent/CN111943939B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/34Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
    • A01N43/36Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings
    • A01N43/38Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom five-membered rings condensed with carbocyclic rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/584Recycling of catalysts

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Indole Compounds (AREA)

Abstract

The invention provides a synthesis method of chromanone compounds and agricultural biological activity thereof, belonging to the field of organic synthesis. The technical scheme comprises the steps of respectively adding a 2- (allyloxy) benzaldehyde compound and 2-hydroxy isoindoline-1, 3-diketone into a reactor, and heating and reacting in a closed manner for 5-8 hours at 50-100 ℃ in the presence of a catalyst and a eutectic solvent; and after the reaction is finished, performing column chromatography separation to obtain the chromanone compounds. The compound synthesized by the invention can be applied to the control of apple tree canker Valsa mali and citrus anthracnose Colletotrichum gloeosporioides Penz singly or in combination.

Description

Synthesis method of chromanone compound and agricultural biological activity thereof
Technical Field
The invention belongs to the field of organic synthesis, and particularly relates to a synthesis method of chromanone compounds and agricultural biological activity thereof.
Background
Chromanone compounds have various biological activities, have achieved various satisfactory effects in recent years, and are receiving increasing attention from chemical researchers all over the world. Currently, a currently available method for preparing chromanone compounds is to use 2- (allyloxy) benzaldehyde compounds and acid compounds to react under the conditions of expensive metallic silver catalysts and organic solvents at high temperature (both chem.commun.2016,52,3661 and adv.synth.catal.2017,359, 2390-2395). However, in the above preparation process, the metal silver catalyst used is expensive and used in a large amount, and the organic solvent is not only not recyclable but also not environmentally friendly. Therefore, the method provided at present is not economical and is not the optimal scheme in the experimental synthesis of the chromanone compounds.
Disclosure of Invention
The invention provides a synthesis method of chromanone compounds and agricultural biological activity thereof, the synthesis method has simple reaction system, does not need to use metal catalyst, can recycle solvent and provides a brand-new method for green synthesis of chromanone compounds.
In order to achieve the above object, the present invention provides a method for synthesizing chromanone compounds, comprising the steps of:
respectively adding a 2- (allyloxy) benzaldehyde compound and 2-hydroxyisoindoline-1, 3-diketone into a reactor, and carrying out closed heating reaction for 5-8 hours at 50-100 ℃ in the presence of a catalyst and a eutectic solvent;
and after the reaction is finished, performing column chromatography separation to obtain the chromanone compounds.
Preferably, the 2- (allyloxy) benzaldehyde compound has the following structural formula (A):
Figure BDA0002612612360000021
wherein,R1Selected from any one of hydrogen, chloro and tert-butyl, R2Selected from any one of hydrogen and methoxy, R3Any one selected from hydrogen, chloro and tert-butyl.
Preferably, the eutectic solvent is a mixture of choline chloride and urea.
Preferably, the molar ratio of choline chloride to urea in the eutectic solvent is 1: 1.
Preferably, the chromanone compound has the following structural formula (B):
Figure BDA0002612612360000022
wherein R is4Selected from any one of hydrogen, chloro and tert-butyl, R5Selected from any one of hydrogen and methoxy, R6Any one selected from hydrogen, chloro and tert-butyl.
Preferably, the catalyst is 2, 3-dichloro-5, 6-dicyan-p-benzoquinone or persulfate, wherein the persulfate is potassium persulfate or sodium persulfate.
Preferably, the millimole ratio of the 2- (allyloxy) benzaldehyde compound, the 2-hydroxyisoindoline-1, 3-diketone and the catalyst is 1:1: 2.
Preferably, the chromatographic column used in the column chromatography is a silica gel column, and the eluent used is a mixture of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether is 1:5-2: 1.
The invention also provides application of the chromanone compound synthesized by the synthesis method according to any one of the technical schemes in prevention and treatment of apple tree canker Valsa mali and citrus anthracnose Colletotrichum gloeosporioides Penz.
Compared with the prior art, the invention has the advantages and positive effects that:
the synthesis method provided by the invention takes the 2- (allyloxy) benzaldehyde compound and the nitrobenzene compound as basic raw materials, and can complete the reaction by using cheap and easily obtained persulfate or DDQ under the condition of no need of a metal catalyst and an organic solvent. The synthesis method has the advantages that the reaction system is simple, the used solvent is a eutectic solvent, the solvent can be effectively recycled, the efficiency can still be maintained without being obviously reduced after the solvent is recycled for 8 times, the reaction can be completed under the air condition, the reaction time is short, the yield is high, and an optimal solution is provided for green synthesis of the chromanone compounds.
Detailed Description
The technical solutions in the embodiments of the present invention will be clearly and completely described below, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
The embodiment of the invention provides a synthesis method of chromanone compounds, which comprises the following steps:
s1: respectively adding 2- (allyloxy) benzaldehyde compounds and 2-hydroxy isoindoline-1, 3-diketone into a reactor, and heating and reacting in a closed manner at 50-100 ℃ for 5-8 hours under the action of a catalyst and a eutectic solvent.
In the step, 2- (allyloxy) benzaldehyde compounds and 2-hydroxy isoindoline-1, 3-dione are utilized to synthesize chromanone compounds, specifically, under the heating condition, a catalyst DDQ or potassium persulfate is used for capturing hydrogen atoms of the 2-hydroxy isoindoline-1, 3-dione under the action of a eutectic solvent to generate free radicals, the free radicals are added with double bonds in the 2- (allyloxy) benzaldehyde compounds to generate carbon free radicals, the carbon free radicals and aldehyde groups are subjected to intramolecular cyclization reaction to generate oxygen free radicals, and finally the hydrogen free radicals are captured to generate target products. It should be noted here that the reaction does not need metal catalyst, and the eutectic solvent used is recyclable solvent, the method selectivity and economy are both good, and the product yield can be as high as 90%.
The residual eutectic solvent used in the above steps is added into the synthesis of new chromanone compounds, and can be recycled for 8 times without obvious reduction of yield, and the yield data is as follows (the recycling test is carried out by taking the following P1 compound as an example): :
Figure BDA0002612612360000031
Figure BDA0002612612360000041
s2: and after the reaction is finished, performing column chromatography separation to obtain the chromanone compounds.
In a preferred embodiment, the 2- (allyloxy) benzaldehyde compound has the following structural formula (a):
Figure BDA0002612612360000042
wherein R is1Selected from any one of hydrogen, chloro and tert-butyl, R2Selected from any one of hydrogen and methoxy, R3Any one selected from hydrogen, chloro and tert-butyl.
In a preferred embodiment, the eutectic solvent is a mixture of choline chloride and urea in a molar ratio of 1: 1. In a preferred embodiment, the catalyst is 2, 3-dichloro-5, 6-dicyan-p-benzoquinone or potassium persulfate.
In a preferred embodiment, the chromanone compound has the following structural formula (B):
Figure BDA0002612612360000043
wherein R is4Selected from any one of hydrogen, chloro and tert-butyl, R5Selected from any one of hydrogen and methoxy, R6Any one selected from hydrogen, chloro and tert-butyl.
Specifically, it may be selected from any one of the following compounds:
Figure BDA0002612612360000051
In a preferred embodiment, the millimolar ratio of the 2- (allyloxy) benzaldehyde compound, the 2-hydroxyisoindoline-1, 3-dione and the catalyst is 1:1: 2. In this example, specific ratios of the 2- (allyloxy) benzaldehyde compound, 2-hydroxyisoindoline-1, 3-dione, and catalyst are given, wherein the ratio of the 2- (allyloxy) benzaldehyde compound, 2-hydroxyisoindoline-1, 3-dione, and catalyst is set based on the reaction mechanism requirements, and the amount of solvent added is relatively excessive to ensure sufficient reaction, in order to obtain the desired core structure of the compound accurately.
In a preferred embodiment, the chromatographic column used in the column chromatography is a silica gel column, and the eluent used is a mixture of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether is 1:5-2: 1. In this example, the product obtained by the reaction was subjected to gradient elution using a silica gel column to isolate the desired synthetic product. In this example, a mixture of ethyl acetate and petroleum ether in a volume ratio of 1:5 to 2:1 is selected for gradient elution according to the principle of similar phase solubility and considering the polarity of the synthesized product, and within this range, the skilled person can adjust the elution according to the actual situation.
The embodiment of the invention also provides application of the chromanone compound synthesized by the synthesis method in any one of the embodiments in apple tree canker Valsa mali and citrus Colletotrichum gloeosporioides Penz. Specifically, the prepared compound can be used for protecting and treating apples and citrus by single or combined administration according to needs.
In order to more clearly and specifically describe the synthesis method of the chromanone compounds and the agricultural biological activity thereof provided in the embodiments of the present invention, the following description will be given with reference to specific examples.
Example 1
1mmol of the mixture is added into a reactor respectively
Figure BDA0002612612360000061
1mmol
Figure BDA0002612612360000062
mmol potassium persulfate and 2ml eutectic solvent are sealed and heated for reaction for 5 hours at 60 ℃ under the air condition; after the reaction was completed, column chromatography was performed to obtain the following P1 compound:
Figure BDA0002612612360000063
the above yellow solid powder was subjected to nuclear magnetic spectrum analysis, and the data were as follows:
1H NMR(500MHz,CDCl3)δ7.88-7.84(m,3H),7.77(dd,J=5.4,3.1Hz,2H),7.52-7.47(m,1H),7.05-6.99(m,2H),4.94(dd,J=11.5,4.9Hz,1H),4.74-4.65(m,2H),4.41(t,J=10.0Hz,1H),3.34(ddd,J=14.2,9.4,4.4Hz,1H);
13C NMR(126MHz,CDCl3)δ190.6,163.4,161.9,136.3,134.7,128.8,127.3,123.7,121.6,120.6,118.1,74.0,68.6,45.5;
HRMS:m/z C18H13O5NNa[M+Na]+calculated values are 346.06842; theoretical value 346.06859;
after identification, the spectral data correspond to the structural formula, and the synthesized 2- ((4-oxo chroman-3-yl) methoxyl) isoindoline-1, 3-diketone is proved to have the yield of 90 percent.
Example 2
1mmol of the mixture is added into a reactor respectively
Figure BDA0002612612360000064
1mmol
Figure BDA0002612612360000065
2mmol of 2, 3-dichloro-5, 6-dicyan p-benzoquinone and 2ml of eutectic solvent are sealed and heated for reaction for 5 hours at the temperature of 100 ℃ in air; after the reaction was completed, column chromatography was performed to obtain the following P2 compound:
Figure BDA0002612612360000071
The white solid powder was subjected to nuclear magnetic spectrum analysis, and the data were as follows:
1H NMR(500MHz,CDCl3)δ7.85(dd,J=5.4,3.1Hz,2H),7.80-7.76(m,2H),7.73(d,J=2.5Hz,1H),7.57(d,J=2.5Hz,1H),5.09(dd,J=11.6,5.1Hz,1H),4.78(t,J=11.3Hz,1H),4.69(dd,J=10.8,4.1Hz,1H),4.46(dd,J=10.7,8.8Hz,1H),3.37(ddt,J=11.0,9.0,4.7Hz,1H);
13C NMR(126MHz,CDCl3)δ188.9,163.3,156.1,135.8,134.7,128.7,126.8,125.3,124.0,123.7,122.1,73.5,69.4,45.0;
HRMS:m/z C18H11O5NCl2Na[M+Na]+calculated value 413.99023; theoretical value 413.99065;
after identification, the spectral data correspond to the structural formula, and the synthesized product is 2- ((6, 8-dichloro-4-oxochroman-3-yl) methoxy) isoindoline-1, 3-dione with the yield of 91 percent.
Example 3
1mmol of the mixture is added into a reactor respectively
Figure BDA0002612612360000072
1mmol
Figure BDA0002612612360000073
2mmol potassium persulfate and 2ml eutectic solvent are sealed and heated for reaction for 8 hours at 50 ℃ under the air condition; after the reaction was completed, column chromatography was performed to obtain the following P3 compound:
Figure BDA0002612612360000074
the white solid powder was subjected to nuclear magnetic spectrum analysis, and the data were as follows:
1H NMR(500MHz,CDCl3)δ7.85(dd,J=5.4,3.1Hz,2H),7.81-7.74(m,3H),6.57(dd,J=8.8,2.4Hz,1H),6.45(d,J=2.4Hz,1H),4.90(dd,J=11.4,4.8Hz,1H),4.69(ddd,J=10.5,10.0,6.9Hz,2H),4.39(t,J=10.1Hz,1H),3.85(s,3H),3.26(ddd,J=14.1,9.6,4.4Hz,1H);
13C NMR(126MHz,CDCl3)δ189.1,166.3,163.9,163.4,134.6,129.0,128.8,123.6,114.5,110.3,100.7,74.2,68.8,55.7,45.1;HRMS:m/z C19H15O6NNa[M+Na]+calculated value 376.07858; theoretical value 376.07916;
after identification, the spectral data correspond to the structural formula, and the synthesized 2- ((7-methoxy-4-oxochroman-3-yl) methoxy) isoindoline-1, 3-dione is proved to be obtained with the yield of 93 percent.
Example 4
1mmol of the mixture is added into a reactor respectively
Figure BDA0002612612360000081
1mmol
Figure BDA0002612612360000082
2mmol potassium persulfate and 2ml eutectic solvent are sealed and heated for reaction for 8 hours at 60 ℃ under the air condition; after the reaction was completed, column chromatography was performed to obtain the following P4 compound:
Figure BDA0002612612360000083
the white solid powder was subjected to nuclear magnetic spectrum analysis, and the data were as follows:
1H NMR(500MHz,CDCl3)δ7.85(dd,J=5.5,3.1Hz,2H),7.81-7.75(m,3H),7.43(dd,J=8.9,2.7Hz,1H),6.99(d,J=8.9Hz,1H),4.95(dd,J=11.6,5.0Hz,1H),4.74-4.60(m,2H),4.41(dd,J=10.6,9.2Hz,1H),3.41-3.26(m,1H);
13C NMR(126MHz,CDCl3)δ189.6,163.4,160.3,136.2,134.7,128.7,127.1,126.5,123.7,121.4,119.8,73.7,68.7,45.2;
HRMS:m/z C18H12O5NClNa[M+Na]+calculated value 380.02911; theory of the invention A value of 380.02962;
after identification, the spectral data correspond to the structural formula, and the synthesized 2- ((6-chloro-4-oxochroman-3-yl) methoxy) isoindoline-1, 3-dione is proved to have the yield of 95%.
Example 5
1mmol of the mixture is added into a reactor respectively
Figure BDA0002612612360000091
1mmol
Figure BDA0002612612360000092
2mmol of 2, 3-dichloro-5, 6-dicyan p-benzoquinone and 2ml of eutectic solvent are sealed and heated for reaction for 7 hours at 80 ℃ in air; after the reaction was completed, column chromatography was performed to obtain the following P5 compound:
Figure BDA0002612612360000093
the white solid powder was subjected to nuclear magnetic spectrum analysis, and the data were as follows:
1H NMR(500MHz,CDCl3)δ7.85(dd,J=5.4,3.1Hz,2H),7.80-7.73(m,3H),7.57(d,J=2.5Hz,1H),4.92(dd,J=11.3,4.7Hz,1H),4.69(ddd,J=9.8,7.4,3.3Hz,2H),4.41(t,J=10.1Hz,1H),3.39-3.21(m,1H),1.42(s,9H),1.30(s,9H);
13C NMR(126MHz,CDCl3)δ191.5,163.4,159.1,143.5,138.6,134.7,131.1,128.9,123.7,121.2,120.7,74.3,68.0,45.4,35.1,34.5,31.3,29.7;
HRMS:m/z C26H29O5NNa[M+Na]+calculated value 458.19321; theoretical value 458.19379;
after identification, the spectral data correspond to the structural formula, and the synthesized product is 2- ((6, 8-di-tert-butyl-4-oxo chroman-3-yl) methoxyl) isoindoline-1, 3-diketone with the yield of 96 percent.
Performance testing
Weighing 30mg of compound, adding 3mL of acetone, and dissolving to prepare a liquid medicine mother liquor with the concentration of 10000 mg/L; taking 0.5mL of the above mother liquor, adding 2mL of acetone, and dissolving to obtain 2000mg/L medicinal liquid. Adding 2.5mL of the liquid medicine with the concentration of 2000mg/L into 100mL of the molten PDA culture medium, fully and uniformly mixing to prepare a toxic culture medium, uniformly pouring the toxic culture medium into 6 culture dishes with the length of 6cm, and cooling to form a flat plate. 2.5mL of acetone was added to 100mL of melted PDA medium as a blank (CK). The apple rot and the citrus anthracnose germ cakes are respectively inoculated to the PDA culture medium for culture, and each treatment is repeated three times. The inoculated plates were sealed and placed in an incubator (28 ℃) for culture, and the colony diameter was measured when the colonies of the white control strain grew to about 3/4 in the petri dish. The colony growth inhibition rate was calculated according to the following formula, and the test results are shown in table 1.
Inhibition/% ([ control colony diameter-treated colony diameter ]/control colony diameter × 100)
TABLE 1 controlling effect of each compound at 50mg/L
Figure BDA0002612612360000101
As can be seen from the data in Table 1, the compounds prepared by the above embodiments of the present invention have good control effect on apple tree canker, especially the P5 compound shows more excellent treatment effect at 50mg/L, and the treatment effect can reach more than 80; similarly, the compounds have good control effects on the citrus anthracnose pathogen, particularly the P1 compound has more excellent treatment effect at 50mg/L, and the treatment effect can reach more than 90; therefore, in order to effectively exert a controlling effect, the compounds prepared in the above examples may be selected for use alone or in combination in order to obtain a better controlling effect.

Claims (7)

1. The synthesis method of the chromanone compound is characterized by comprising the following steps:
respectively adding a 2- (allyloxy) benzaldehyde compound and 2-hydroxyisoindoline-1, 3-diketone into a reactor, and carrying out closed heating reaction for 5-8 hours at 50-100 ℃ in the presence of a catalyst and a eutectic solvent;
after the reaction is finished, performing column chromatography separation to obtain chromanone compounds;
Wherein, the 2- (allyloxy) benzaldehyde compound has the following structural formula (A):
Figure 33764DEST_PATH_IMAGE001
(A)
R1selected from any one of hydrogen, chloro and tert-butyl, R2Selected from any one of hydrogen and methoxy, R3Any one selected from hydrogen, chloro and tert-butyl;
the catalyst is 2, 3-dichloro-5, 6-dicyan p-benzoquinone or persulfate, and the persulfate is potassium persulfate or sodium persulfate.
2. A synthesis process according to claim 1, characterized in that the eutectic solvent is a mixture of choline chloride and urea.
3. The synthesis method according to claim 2, characterized in that the molar ratio of choline chloride and urea in the eutectic solvent is 1: 1.
4. The method of claim 1, wherein the chromanone compound is of the formula (B):
Figure 232795DEST_PATH_IMAGE002
(B)
wherein R is4Selected from any one of hydrogen, chloro and tert-butyl, R5Selected from any one of hydrogen and methoxy, R6Is selected from any one of hydrogen, chlorine and tertiary butyl.
5. The synthesis method according to claim 1, wherein the millimolar ratio of the 2- (allyloxy) benzaldehyde compound, the 2-hydroxyisoindoline-1, 3-dione and the catalyst is 1:1: 2.
6. The synthesis method according to claim 1, wherein the chromatographic column used in the column chromatography is a silica gel column, and the eluent used is a mixture of ethyl acetate and petroleum ether, and the volume ratio of the ethyl acetate to the petroleum ether is 1:5-2: 1.
7. The chromanone compound synthesized by the synthesis method according to any one of claims 1 to 6 and used for the treatment of apple tree cankerValsa maliAnd Colletotrichum citrinumColletotrichum gloeosporioides PenzApplication in prevention and treatment.
CN202010759339.5A 2020-07-31 2020-07-31 Synthesis method of chromanone compound and agricultural biological activity thereof Active CN111943939B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010759339.5A CN111943939B (en) 2020-07-31 2020-07-31 Synthesis method of chromanone compound and agricultural biological activity thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010759339.5A CN111943939B (en) 2020-07-31 2020-07-31 Synthesis method of chromanone compound and agricultural biological activity thereof

Publications (2)

Publication Number Publication Date
CN111943939A CN111943939A (en) 2020-11-17
CN111943939B true CN111943939B (en) 2022-05-24

Family

ID=73338646

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010759339.5A Active CN111943939B (en) 2020-07-31 2020-07-31 Synthesis method of chromanone compound and agricultural biological activity thereof

Country Status (1)

Country Link
CN (1) CN111943939B (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299364A (en) * 2018-02-06 2018-07-20 常州大学 A kind of synthetic method of 2- methylols chromanone
CN108409699A (en) * 2018-03-22 2018-08-17 常州大学 A kind of synthetic method of 2- alkyl substitution chroman ketone compound
CN109574972A (en) * 2018-07-13 2019-04-05 郑州大学 A kind of 3- alkyl substitution -4- chromanone compound and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108299364A (en) * 2018-02-06 2018-07-20 常州大学 A kind of synthetic method of 2- methylols chromanone
CN108409699A (en) * 2018-03-22 2018-08-17 常州大学 A kind of synthetic method of 2- alkyl substitution chroman ketone compound
CN109574972A (en) * 2018-07-13 2019-04-05 郑州大学 A kind of 3- alkyl substitution -4- chromanone compound and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Acyl hydrazines as precursors to acyl radicals;Rebecca Braslau etal.;《Tetrahedron》;20020701;第58卷(第27期);第5513-5523页 *
Copper-Catalyzed α-Aminoxylation of Ketones with 2,2,6,6-Tetra- methylpiperidine-1-oxyl (TEMPO);Ye-Xiane Xie et al.;《Advanced Synthesis & Catalysis》;20131114;第3387–3390页 *

Also Published As

Publication number Publication date
CN111943939A (en) 2020-11-17

Similar Documents

Publication Publication Date Title
CN108033922B (en) Preparation method of 3-acyl quinoxalinone derivative
CN113429330A (en) Method for preparing 2-pyrrolidone derivative through three-component serial cyclization reaction under catalysis of copper
CN111732600B (en) Cuprous complex containing meta-carborane ligand and preparation method and application thereof
CN111943939B (en) Synthesis method of chromanone compound and agricultural biological activity thereof
CN110878099B (en) Preparation method of pyrrole [1,2, alpha ] indole alkaloid derivative
CN113603694B (en) 1, 2-diketone compound and preparation method and application thereof
CN110003083B (en) Process method for preparing S-indoline-2-carboxylic acid by using Ir catalyst
CN110256478B (en) Alkene 1, 2-bifunctional reaction method
CN110183453B (en) Method for preparing 3-phenyl- [1,2,4] triazolo [4,3-a ] pyridine compound under catalysis of no metal
CN113754544A (en) Preparation method of polysubstituted (E) -trifluoromethyl olefin
CN111943924B (en) Synthesis method of chromanone compounds
CN116813525B (en) Synthesis method of polyacetyl substituted oxindole compound
CN110156681B (en) Synthesis method of 2-ester group quinoline
CN110028437B (en) Method for preparing 2-phenyl-3-aldehyde indole compound under microwave promotion
CN112358495B (en) Silicon-containing indoline derivative and preparation method thereof
CN115286547B (en) Method for synthesizing aryl benzyl thioether compound
CN116462619B (en) Preparation method of cyclopentenone derivative
CN111943925B (en) Synthesis method of chromanone compounds
CN110981702B (en) Efficient synthesis method of 2, 3-dibromophenol or derivatives thereof
CN110156683B (en) Synthesis method of quinoline oxide
CN112441935B (en) Synthesis method of beta-aminoketone compound
CN109912470B (en) Synthetic method of 3- (benzenesulfonyl) propionic acid
CN108546244B (en) Synthetic method of 3, 3' -diindolylethane compound
WO2017037296A1 (en) Stable adducts of 2-iodoxybenzoic acid
CN115232047A (en) Preparation method of 3-phenylseleno-1-acetone derivatives

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant